This company has been marked as potentially delisted and may not be actively trading. Genesis Healthcare (GEN) Competitors Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipTrendsBuy This Stock GEN vs. CDAY, CCCS, ZI, SVFCX, SEMR, MIXT, XPER, IDN, MAQC, and MTBLYShould you be buying Genesis Healthcare stock or one of its competitors? The main competitors of Genesis Healthcare include Ceridian HCM (CDAY), CCC Intelligent Solutions (CCCS), ZoomInfo Technologies (ZI), Smead Value C (SVFCX), Semrush (SEMR), MiX Telematics (MIXT), Xperi (XPER), Intellicheck (IDN), Maquia Capital Acquisition (MAQC), and Moatable (MTBLY). Genesis Healthcare vs. Its Competitors Ceridian HCM CCC Intelligent Solutions ZoomInfo Technologies Smead Value C Semrush MiX Telematics Xperi Intellicheck Maquia Capital Acquisition Moatable Genesis Healthcare (NYSE:GEN) and Ceridian HCM (NYSE:CDAY) are both prepackaged software industry companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, institutional ownership, valuation, media sentiment, analyst recommendations, risk, profitability and earnings. Do analysts rate GEN or CDAY? Genesis Healthcare currently has a consensus target price of $33.25, indicating a potential upside of 9.84%. Given Genesis Healthcare's stronger consensus rating and higher possible upside, analysts plainly believe Genesis Healthcare is more favorable than Ceridian HCM.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Genesis Healthcare 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50Ceridian HCM 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is GEN or CDAY more profitable? Genesis Healthcare has a net margin of 17.83% compared to Ceridian HCM's net margin of 0.28%. Genesis Healthcare's return on equity of 155.48% beat Ceridian HCM's return on equity.Company Net Margins Return on Equity Return on Assets Genesis Healthcare17.83% 155.48% 9.12% Ceridian HCM 0.28%2.03%0.51% Do institutionals & insiders believe in GEN or CDAY? 82.1% of Genesis Healthcare shares are owned by institutional investors. 3.3% of Genesis Healthcare shares are owned by insiders. Comparatively, 4.5% of Ceridian HCM shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has more risk & volatility, GEN or CDAY? Genesis Healthcare has a beta of 0.84, indicating that its stock price is 16% less volatile than the S&P 500. Comparatively, Ceridian HCM has a beta of 1.38, indicating that its stock price is 38% more volatile than the S&P 500. Which has higher earnings and valuation, GEN or CDAY? Genesis Healthcare has higher revenue and earnings than Ceridian HCM. Genesis Healthcare is trading at a lower price-to-earnings ratio than Ceridian HCM, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGenesis Healthcare$2.80B6.92$836M$0.9033.63Ceridian HCM$1.45B6.41-$73.40M$0.031,983.00 Does the media refer more to GEN or CDAY? In the previous week, Genesis Healthcare had 1 more articles in the media than Ceridian HCM. MarketBeat recorded 2 mentions for Genesis Healthcare and 1 mentions for Ceridian HCM. Ceridian HCM's average media sentiment score of 0.59 beat Genesis Healthcare's score of 0.00 indicating that Ceridian HCM is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Genesis Healthcare 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Ceridian HCM 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryGenesis Healthcare beats Ceridian HCM on 12 of the 16 factors compared between the two stocks. Get Genesis Healthcare News Delivered to You Automatically Sign up to receive the latest news and ratings for GEN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GEN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GEN vs. The Competition Export to ExcelMetricGenesis HealthcarePrepackaged software IndustryBusiness SectorNYSE ExchangeMarket Cap$19.35B$8.00B$14.73B$20.78BDividend Yield3.05%0.89%2.74%3.60%P/E Ratio33.63157.4828.5927.73Price / Sales6.924.2848.3367.59Price / Cash8.4257.6027.1523.29Price / Book-189.194.055.914.52Net Income$836M$77.43M$196.26M$993.74M Genesis Healthcare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GENGenesis Healthcare0.5756 of 5 stars$30.27-0.8%$33.25+9.8%+17.1%$19.35B$2.80B33.632,700CDAYCeridian HCM1.649 of 5 stars$58.25+1.1%N/A+13.1%$9.09B$1.45B1,942.318,526CCCSCCC Intelligent Solutions2.5782 of 5 stars$9.69-0.7%$12.06+24.5%-10.2%$6.39B$969.13M484.742,350News CoveragePositive NewsUpcoming EarningsAnalyst ForecastZIZoomInfo Technologies0.2493 of 5 stars$10.41-0.4%$10.63+2.1%+1.2%$3.56B$1.21B347.123,540Upcoming EarningsSVFCXSmead Value CN/A$73.17-0.3%N/AN/A$3.00BN/A0.002SEMRSemrush3.3346 of 5 stars$9.04+1.4%$16.43+81.8%-35.3%$1.34B$396.02M112.981,170MIXTMiX TelematicsN/A$14.55flatN/AN/A$353.75M$150.06M58.201,080XPERXperi2.2079 of 5 stars$7.61-0.7%$19.00+149.8%-19.3%$346.16M$488.88M-4.002,100Trending NewsUpcoming EarningsAnalyst ForecastIDNIntellicheck1.2301 of 5 stars$5.46+4.4%$5.83+6.8%+65.0%$108.35M$20.21M-182.0050News CoverageHigh Trading VolumeMAQCMaquia Capital AcquisitionN/A$11.30flatN/AN/A$58.99MN/A0.004MTBLYMoatableN/A$1.35+8.0%N/A+112.5%$24.06M$52.07M-13.50410 Related Companies and Tools Related Companies CDAY Alternatives CCCS Alternatives ZI Alternatives SVFCX Alternatives SEMR Alternatives MIXT Alternatives XPER Alternatives IDN Alternatives MAQC Alternatives MTBLY Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:GEN) was last updated on 7/30/2025 by MarketBeat.com Staff From Our PartnersAI Frenzy Could Send ‘EarnPhone’ SoaringThe hidden fuel behind AI? Your phone. Billions of data points — from your clicks, swipes, scrolls, and sea...Mode Mobile | SponsoredNvidia’s next AI move could catch traders flat-footedTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredEx-Hedge Fund Manager Uncovers $100 Trillion Land ShiftTrump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to u...Stansberry Research | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredThe Fed Just Froze You Out (Again)The Fed’s holding rates steady—again. No clarity. No yield. No relief. But one income strategy is quietly t...Investors Alley | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredSomething BIG is about to hit the stock marketMost investors won’t see it coming—but Weiss Ratings says a major market event is brewing. Their system jus...Weiss Ratings | SponsoredThe $1 Trillion Event Tesla Still Hasn’t Recovered FromIn 2010, a “Flash Crash” erased $1 trillion in minutes. Now, one trading legend says it’s happening again—insi...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genesis Healthcare, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Genesis Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
